Evaxion

Evaxion A/S is a pioneering TechBio company based on its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies against cancer, bacterial diseases, and viral infections. Based on AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline targeting bacterial and viral diseases with significant unmet medical needs.

The task for Zystm was to create a laboratory and animal facility where Evaxion could grow and carry out its groundbreaking research. The facility was established at the DTU Science Park in Hørsholm and DK2 by Per Hald. This project was completed on schedule and in close collaboration with NNE architect Hans-Erik Andersen and project manager Leif Ølgaard.

Facts

Description: Design and furnishing of laboratory and animal facility
Architect: NNE, Hans-Erik Andersen
Project Manager: LBO Consult ApS, Leif Ølgaard